(P-2) Public Health and Economic Impact of Implementing Gender-Neutral Vaccination with the 4-Valent Human Papillomavirus Vaccine in Costa Rica

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

AR

Ana Marisol Rendon, MD, MS

MSD Panama
Panama, Panama, Panama
BL

Bruna Cristina Lima, n/a

MSD Brazil
São, Sao Paulo, Brazil
AP

Andrew Pavelyev, n/a

Merck&Co.,Inc.
Rahway, New Jersey, United States
VD

Vincent Daniels, PhD

Merck&Co.,Inc.
Rahway, New Jersey, United States
KS

Kunal Saxena, PhD

Merck&Co.,Inc.
Rahway, New Jersey, United States
WH

Wilberth Herrera-Solano, MD

Caja Costarricense de Seguro Social
San Jose, San Jose, Costa Rica
Cintia I. Parellada, MD, PhD (she/her/hers)

Executive Director Outcomes Research
MSD Brazil
São Paulo, Sao Paulo, Brazil